Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
HebeCell
AddedFeb 17, 2024
UpdatedJun 18, 2026
HebeCell

HebeCell

Series A

MA-based HebeCell pioneers in immuno-oncology and regenerative medicine through cell-based therapeutics.

HQ
Natick, MA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Founded in Natick, MA, HebeCell is a biotech company dedicated to advancing cell-based therapeutics for immuno-oncology and regenerative medicine. The company's mission is to develop and commercialize innovative treatments for incurable diseases, leveraging groundbreaking, patented technologies to restore health at the cellular level. HebeCell focuses on creating therapies that combat disease and promote cellular rejuvenation, aiming to make significant contributions to both regenerative medicine and cancer treatment.

HebeCell has attracted notable investors and experts in the biotech field, contributing to its rapid growth and recognition. The company has achieved significant milestones, including the development of proprietary technologies that have the potential to revolutionize treatment paradigms in their target markets. HebeCell's impact is marked by its commitment to addressing unmet medical needs and its potential to transform therapeutic approaches in immuno-oncology and regenerative medicine.

HebeCell - Similar Companies

Celularity logo

Celularity

celularity.com

Cellular Approaches logo

Cellular Approaches

Be Biopharma logo

Be Biopharma

Cell BioEngines logo

Cell BioEngines

cellbioengines.com

Hepatx logo

Hepatx

hepatx.com

Cellino logo

Cellino

cellinobio.com

AgeX Therapeutics logo

AgeX Therapeutics

ViaCyte logo

ViaCyte

Spheringenics logo

Spheringenics

Platelet BioGenesis logo

Platelet BioGenesis

Celltheon logo

Celltheon

celltheon.com

Stemedica Cell Technologies logo

Stemedica Cell Technologies

stemedica.com

Cellevolve Bio logo

Cellevolve Bio

cellevolve.com

Pathfinder Cell Therapy logo

Pathfinder Cell Therapy

Cell Care Therapeutics logo

Cell Care Therapeutics

cell-care.com

HebeCell - Quick Facts

Who are HebeCell's competitors?

Companies similar to HebeCell include Celularity, Cellular Approaches, Be Biopharma and Cell BioEngines.

When was HebeCell founded?

HebeCell was founded in 2016.

Where is HebeCell's headquarters located?

HebeCell's headquarters is located in Natick, MA, US.

When was HebeCell's last funding round?

HebeCell's most recent funding round was for $53M (USD) in August 2021.

How much has HebeCell raised to-date?

As of Aug 31, 2021, HebeCell has raised a total of $63M (USD).

How many employees does HebeCell have?

HebeCell has 24 employees as of Feb 4, 2024.

HebeCell - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Customer
  • Enterprise
Main Product
  • Cell Therapies
Tags
  • Consulting
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified